Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Silymarin Constituent 2,3-Dehydrosilybin Triggers Reserpine-Sensitive Positive Inotropic Effect in Perfused Rat Heart

E. Gabrielová, AV. Zholobenko, L. Bartošíková, J. Nečas, M. Modriansky,

. 2015 ; 10 (9) : e0139208. [pub] 20150929

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

2,3-dehydrosilybin (DHS) is a minor flavonolignan component of Silybum marianum seed extract known for its hepatoprotective activity. Recently we identified DHS as a potentially cardioprotective substance during hypoxia/reoxygenation in isolated neonatal rat cardiomyocytes. This is the first report of positive inotropic effect of DHS on perfused adult rat heart. When applied to perfused adult rat heart, DHS caused a dose-dependent inotropic effect resembling that of catecholamines. The effect was apparent with DHS concentration as low as 10 nM. Suspecting direct interaction with β-adrenergic receptors, we tested whether DHS can trigger β agonist-dependent gene transcription in a model cell line. While DHS alone was unable to trigger β agonist-dependent gene transcription, it enhanced the effect of isoproterenol, a known unspecific β agonist. Further tests confirmed that DHS could not induce cAMP accumulation in isolated neonatal rat cardiomyocytes even though high concentrations (≥ 10 μM) of DHS were capable of decreasing phosphodiesterase activity. Pre-treatment of rats with reserpine, an indole alkaloid which depletes catecholamines from peripheral sympathetic nerve endings, abolished the DHS inotropic effect in perfused hearts. Our data suggest that DHS causes the inotropic effect without acting as a β agonist. Hence we identify DHS as a novel inotropic agent.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16020254
003      
CZ-PrNML
005      
20160722120001.0
007      
ta
008      
160722s2015 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0139208 $2 doi
024    7_
$a 10.1371/journal.pone.0139208 $2 doi
035    __
$a (PubMed)26418338
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Gabrielová, Eva $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic.
245    10
$a Silymarin Constituent 2,3-Dehydrosilybin Triggers Reserpine-Sensitive Positive Inotropic Effect in Perfused Rat Heart / $c E. Gabrielová, AV. Zholobenko, L. Bartošíková, J. Nečas, M. Modriansky,
520    9_
$a 2,3-dehydrosilybin (DHS) is a minor flavonolignan component of Silybum marianum seed extract known for its hepatoprotective activity. Recently we identified DHS as a potentially cardioprotective substance during hypoxia/reoxygenation in isolated neonatal rat cardiomyocytes. This is the first report of positive inotropic effect of DHS on perfused adult rat heart. When applied to perfused adult rat heart, DHS caused a dose-dependent inotropic effect resembling that of catecholamines. The effect was apparent with DHS concentration as low as 10 nM. Suspecting direct interaction with β-adrenergic receptors, we tested whether DHS can trigger β agonist-dependent gene transcription in a model cell line. While DHS alone was unable to trigger β agonist-dependent gene transcription, it enhanced the effect of isoproterenol, a known unspecific β agonist. Further tests confirmed that DHS could not induce cAMP accumulation in isolated neonatal rat cardiomyocytes even though high concentrations (≥ 10 μM) of DHS were capable of decreasing phosphodiesterase activity. Pre-treatment of rats with reserpine, an indole alkaloid which depletes catecholamines from peripheral sympathetic nerve endings, abolished the DHS inotropic effect in perfused hearts. Our data suggest that DHS causes the inotropic effect without acting as a β agonist. Hence we identify DHS as a novel inotropic agent.
650    _2
$a zvířata $7 D000818
650    _2
$a kardiotonika $x farmakologie $7 D002316
650    _2
$a buněčné linie $7 D002460
650    _2
$a srdce $x účinky léků $7 D006321
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ostropestřec mariánský $7 D020944
650    _2
$a kontrakce myokardu $x účinky léků $7 D009200
650    _2
$a kardiomyocyty $x fyziologie $7 D032383
650    _2
$a rostlinné přípravky $x farmakologie $7 D028321
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a reserpin $x farmakologie $7 D012110
650    _2
$a silymarin $x farmakologie $7 D012838
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Zholobenko, Aleksey Vladimirovich $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic.
700    1_
$a Bartošíková, Lenka $u Department of Physiology, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic.
700    1_
$a Nečas, Jiří $u Department of Physiology, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic.
700    1_
$a Modriansky, Martin $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic.
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 10, č. 9 (2015), s. e0139208
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26418338 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160722 $b ABA008
991    __
$a 20160722120215 $b ABA008
999    __
$a ok $b bmc $g 1154924 $s 944782
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 10 $c 9 $d e0139208 $e 20150929 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20160722

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...